MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.

MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells. Oncol Rep. 2019 Apr; 41(4):2540-2548.

View in: PubMed

subject areas

Apoptosis
Cell Line, Tumor
Cell Proliferation
Down-Regulation
Gene Expression Regulation, Neoplastic
Gene Knockdown Techniques
Head and Neck Neoplasms
Humans
Naphthyridines
Neoplastic Stem Cells
Promoter Regions, Genetic
RNA, Small Interfering
SOXB1 Transcription Factors

authors with profiles

Yusuke Nakamura